Peptides for use in treating obesity

Details for Australian Patent Application No. 2004235872 (hide)

Owner Novo Nordisk A/S

Inventors Hansen, Thomas Kruse; Madsen, Kjeld; Christensen, Leif; Sensfuss, Ulrich; Petterson, Ingrid Vivika; Ankersen, Michael; Conde Frieboes, Kilian Waldemar

Agent Shelston IP

Pub. Number AU-A-2004235872

PCT Pub. Number WO2004/099246

Priority 60/543,962 12.02.04 US; 60/470,639 15.05.03 US; PA 2003 00706 09.05.03 DK; PA 2004 00172 05.02.04 DK

Filing date 5 May 2004

Wipo publication date 18 November 2004

International Classifications

C07K 014/68 Peptides having more than 20 amino acids

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 007/04 Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/099246 Priority application(s): WO2004/099246

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235874-A method for dispensing a beverage and devices therefor

2004235848-Hepatitis C virus NS5B polymerase inhibitor binding pocket